S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Better Than Oil Stocks (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Better Than Oil Stocks (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Better Than Oil Stocks (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Better Than Oil Stocks (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
NASDAQ:OFIX

Orthofix Medical (OFIX) Stock Forecast, Price & News

$12.86
-0.08 (-0.62%)
(As of 09/29/2023 ET)
Compare
Today's Range
$12.80
$13.11
50-Day Range
$12.40
$21.36
52-Week Range
$12.25
$23.19
Volume
452,642 shs
Average Volume
769,943 shs
Market Capitalization
$472.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.00

Orthofix Medical MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
24.4% Upside
$16.00 Price Target
Short Interest
Healthy
3.24% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.72mentions of Orthofix Medical in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$101,025 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.66) to ($0.43) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

679th out of 970 stocks

Surgical & Medical Instruments Industry

72nd out of 99 stocks


OFIX stock logo

About Orthofix Medical (NASDAQ:OFIX) Stock

Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions. Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine, which design, develop, and market the orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. It sells its products through distributors, sales representatives, hospitals, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.

OFIX Price History

OFIX Stock News Headlines

His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Orthofix Ongoing Investor Alert
Orthofix Shareholder Action Reminder
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
BTIG Downgrades Orthofix Medical (OFIX)
JMP Securities Sticks to Their Hold Rating for Orthofix (OFIX)
See More Headlines
Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Company Calendar

Last Earnings
8/08/2023
Today
9/30/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:OFIX
CUSIP
N6748L10
Employees
1,092
Year Founded
1980

Price Target and Rating

Average Stock Price Forecast
$16.00
High Stock Price Forecast
$16.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+24.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-19,750,000.00
Pretax Margin
-19.15%

Debt

Sales & Book Value

Annual Sales
$598.45 million
Cash Flow
$1.88 per share
Book Value
$16.71 per share

Miscellaneous

Free Float
35,012,000
Market Cap
$472.46 million
Optionable
Optionable
Beta
0.85

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Ms. Catherine M. Burzik M.A.Ms. Catherine M. Burzik M.A. (Age 73)
    MA, Interim CEO & Chair of the Board
    Comp: $137.5k
  • Ms. Kimberley A. EltingMs. Kimberley A. Elting (Age 58)
    Pres of Global Orthopedics
    Comp: $766.67k
  • Mr. Kevin J. Kenny (Age 58)
    Pres of Global Spine Bus.
    Comp: $607.64k
  • Mr. Geoffrey C. Gillespie
    VP, Corp. Controller & Interim CFO
  • Mr. Roberto Donadello
    Sr. VP of Global Operations
  • Dr. Frank Vizesi Ph.D.
    Chief Scientific Officer
  • Mr. Dan E. Yarbrough
    VP of Investor Relations
  • Ms. Puja Leekha
    Sr. VP, Chief Ethics & Compliance Officer and Interim Chief Legal Officer
  • Ms. Suzanne Armstrong
    Chief HR Officer
  • Mr. Ehab M. Esmail (Age 51)
    Sr. VP of Global Quality, Regulatory & Clinical Affairs













OFIX Stock - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OFIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares.
View OFIX analyst ratings
or view top-rated stocks.

What is Orthofix Medical's stock price forecast for 2023?

2 equities research analysts have issued 12 month price objectives for Orthofix Medical's stock. Their OFIX share price forecasts range from $16.00 to $16.00. On average, they anticipate the company's stock price to reach $16.00 in the next year. This suggests a possible upside of 24.4% from the stock's current price.
View analysts price targets for OFIX
or view top-rated stocks among Wall Street analysts.

How have OFIX shares performed in 2023?

Orthofix Medical's stock was trading at $20.53 at the start of the year. Since then, OFIX stock has decreased by 37.4% and is now trading at $12.86.
View the best growth stocks for 2023 here
.

Are investors shorting Orthofix Medical?

Orthofix Medical saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,190,000 shares, an increase of 84.0% from the August 31st total of 646,600 shares. Based on an average daily trading volume, of 385,600 shares, the short-interest ratio is presently 3.1 days.
View Orthofix Medical's Short Interest
.

When is Orthofix Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our OFIX earnings forecast
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) posted its quarterly earnings data on Tuesday, August, 8th. The medical device company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.67) by $0.69. The medical device company had revenue of $187.02 million for the quarter, compared to analysts' expectations of $183.80 million. Orthofix Medical had a negative trailing twelve-month return on equity of 1.90% and a negative net margin of 19.74%.

What ETF holds Orthofix Medical's stock ?

Syntax Stratified SmallCap ETF holds 3,764 shares of OFIX stock, representing 0.39% of its portfolio.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical updated its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $752.00 million-$758.00 million, compared to the consensus revenue estimate of $750.57 million.

What is Brad Mason's approval rating as Orthofix Medical's CEO?

32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

How do I buy shares of Orthofix Medical?

Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $12.86.

How much money does Orthofix Medical make?

Orthofix Medical (NASDAQ:OFIX) has a market capitalization of $472.46 million and generates $598.45 million in revenue each year. The medical device company earns $-19,750,000.00 in net income (profit) each year or ($3.66) on an earnings per share basis.

How many employees does Orthofix Medical have?

The company employs 1,092 workers across the globe.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The official website for the company is www.orthofix.com. The medical device company can be reached via phone at (214) 937-2000, via email at markquick@orthofix.com, or via fax at 599 9 461 6978.

This page (NASDAQ:OFIX) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -